Delivery Order SPE2DE24DA010-SPE2D625F0WJ7
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $29.7K fixed-price delivery order with economic price adjustment authority for the AVEIR leadless pacemaker system. The award, issued on June 18, 2025, with an ultimate completion date of June 24, 2025, represents a child contract under Abbott's broader relationship with the Defense Logistics Agency's Medical Supply Chain. The contract involves delivery to Santa Clara, California, and was awarded through full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order with economic price adjustment for the AVEIR leadless pacemaker system on September 12, 2025. The contract, issued by the Defense Logistics Agency's Medical Supply Chain organization, will be performed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order was awarded without a set-aside designation, indicating full and open...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $49.8K by the Department of Defense's Medical Supply Chain for the delivery of Aveir Leadless Pacemakers. The contract, awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition. The award represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $10,500 by the Medical Supply Chain, a defense-focused federal agency, on September 12, 2025. The contract, designated as AVEIR (likely referencing Abbott's Aveir Leadless Pacemaker technology), involves delivery to Santa Clara, California, with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $14,850 by the Department of Defense's Medical Supply Chain on July 24, 2025, with an ultimate completion date of July 29, 2025. The contract is for the AVEIR product line and will be performed in Santa Clara, California. This delivery order was issued without a set-aside designation, indicating full and open competition. The award represents a task order under Abbott's broader...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 fixed-price delivery order with economic price adjustment for leadless accessories by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract, with an ultimate completion date of July 31, 2025, represents a child award under Abbott's broader federal cardiovascular medical device portfolio. No set-aside designation was applied to this award, indicating full and open competition....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order (Contract No. 4569453256) for AVEIR products by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with an ultimate completion date of September 17, 2025. The work will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition among qualified vendors. Abbott Vascular has...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F0WJ7Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $28,350 fixed-price delivery order with economic price adjustment for the supply of Aveir Leadless Pacemakers. The award, issued on June 4, 2025, is set to conclude by June 10, 2025, and represents a child contract under Abbott Laboratories Inc.'s parent entity. The contract was awarded without set-aside designation, indicating full and open competition, and will be performed in Santa Clara, California. The funding originates from the Defense Logistics Agency's Medical Supply Chain, a Defense-focused organization responsible for managing medical device procurement and distribution across federal healthcare systems. This delivery order aligns with Abbott Vascular's established role as a critical supplier of advanced cardiovascular technologies to federal agencies, particularly through the Defense Logistics Agency's comprehensive procurement framework. Abbott has secured substantial existing contracts with the agency, including a $117.1 million Indefinite Delivery Contract for cardiovascular procedural packages encompassing devices, instrumentation, and accessories. The Aveir Leadless Pacemaker delivery represents the company's continued support of federal healthcare operations through the provision of sophisticated implantable cardiac devices that address critical medical needs within the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 6/4/25 |